---
title: "Digi International Q3 2026 earnings preview"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294877007.md"
description: "Digi International (DGII) will report Q3 2026 earnings on August 5th after market close. Consensus estimates project EPS of $0.66, up 144.4% year-over-year, and revenue of $132.57 million, a 22.8% increase. Historically, the company has beaten EPS estimates 88% of the time and revenue estimates 75% of the time over the past two years."
datetime: "2026-08-04T21:44:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294877007.md)
  - [en](https://longbridge.com/en/news/294877007.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294877007.md)
generator: "portal-rs"
---

# Digi International Q3 2026 earnings preview

Digi International (DGII) is scheduled to announce Q3 earnings results on Wednesday, August 5th, after market close. The consensus EPS Estimate is $0.66 (+144.4% Y/Y) and the consensus Revenue Estimate is $132.57M (+22.8% Y/Y). Over the last 2 years, DGII has beaten EPS estimates 88% of the time and has beaten revenue estimates 75% of the time. Ove...

### Related Stocks

- [DGII.US](https://longbridge.com/en/quote/DGII.US.md)

## Related News & Research

- [Digi International Secures $350 Million Five-Year Revolving Credit Facility Led by BMO](https://longbridge.com/en/news/297565351.md)
- [Digi Fiscal Q3 2026 Earnings: Revenue Reaches $139 Million as Margins Expand](https://longbridge.com/en/news/295012892.md)
- [Astron Connect GAAP EPS of -$0.01](https://longbridge.com/en/news/297553346.md)
- [AL Sydbank discloses managers’ share transactions under Market Abuse Regulation](https://longbridge.com/en/news/297912628.md)
- [Immix Biopharma highlights NXC-201 CAR-T data in relapsed/refractory AL amyloidosis trial presentation](https://longbridge.com/en/news/297810101.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**